Is there a rationale for high-dose chemotherapy as first line treatment of advanced Hodgkin's disease? German Hodgkin's Lymphoma Study Group (GHSG).
Hasenclever
D
D
Klinik I für Innere Medizin, Universität Köln, Germany.
Schmitz
N
N
Diehl
V
V
D006689:Hodgkin Disease / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D009367:Neoplasm Staging; D012307:Risk Factors